Switching to Progressively Reduced Nicotine Content Cigarettes in Smokers with Low Socioeconomic Status: A Double-Blind Randomized Clinical Trial.

INTRODUCTION The Food and Drug Administration issued an advanced notice of proposed rulemaking for setting a product standard for nicotine levels in cigarettes, with an emphasis on minimally or non-addicting very low nicotine content (VLNC). METHODS A 33-week, two-arm, double-blind randomized trial conducted in Hershey, Pennsylvania, USA and Washington, DC, USA included adult daily cigarette smokers (≥5 cigarettes per day) with less than a college degree, and who had no plans to quit within the next 6 months. Participants were randomized to either Reduced Nicotine Content (RNC) study cigarettes tapered every 3 weeks to a final VLNC (0.2 mg/cigarette) for six weeks or to Usual Nicotine Content (UNC) study cigarettes (11.6 mg/cigarette). Outcomes included acceptability of study cigarettes measured by attrition (primary outcome), compliance, reduction in cigarette dependence and tobacco biomarkers, and post-intervention cessation. RESULTS The RNC (n= 122) vs. UNC (n=123) group had higher attrition (adjusted Hazard Ratio 3.4; 95% confidence interval [CI] 1.99-5.81). At the end of the intervention, cotinine levels were 50% lower in the RNC group (mean group difference -137 ng/mL; 95% CI -172, -102). The RNC group smoked fewer CPD (-4.1; 95% CI -6.44, -1.75) and had lower carbon monoxide levels (-4.0 ppm; 95% CI -7.7, -0.4). Forty seven percent (29/62) of the RNC group were biochemically-confirmed compliant with smoking VLNC cigarettes (mean cotinine= 8.9 ng/ml). At three month follow-up, only compliant VLNC smokers quit with an assisted quit attempt (N=6/22, 27%). CONCLUSIONS This study supports a VLNC standard in cigarettes. IMPLICATIONS Differential dropout and noncompliance indicate some smokers had difficulty transitioning to cigarettes with reduced nicotine. These smokers will benefit from supplemental nicotine in medicinal or noncombustible tobacco products if a nicotine reduction standard is established. Other smokers in the study were able to successfully transition to VLNC cigarettes exclusively and substantially reduced their exposure to nicotine.

[1]  Ahmed Jamal,et al.  Tobacco Product Use Among Adults — United States, 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[2]  Micah L. Berman,et al.  Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[3]  Steven A. Branstetter,et al.  Pharmacokinetic profile of Spectrum reduced nicotine cigarettes. , 2019, Nicotine & Tobacco Research.

[4]  Brian A. King,et al.  Tobacco Product Use Among Adults — United States, 2017 , 2018, MMWR. Morbidity and mortality weekly report.

[5]  Diane J. Martinez,et al.  Clinical trial recruitment of adult African American smokers from economically disadvantaged urban communities , 2018, Journal of Ethnicity in Substance Abuse.

[6]  Jason D. Robinson,et al.  Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial , 2018, JAMA.

[7]  N. Benowitz,et al.  Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation. , 2018, Preventive medicine.

[8]  F. J. McClernon,et al.  Effects of Reduced Nicotine Content Cigarettes on Individual Withdrawal Symptoms Over Time and During Abstinence , 2018, Experimental and clinical psychopharmacology.

[9]  E. Donny,et al.  Cigarette Management System: An operating procedures guide to obtaining and managing investigational tobacco products for regulatory science research , 2018, Contemporary clinical trials communications.

[10]  J. Muscat,et al.  Estimation of compliance with exclusive smoking of very low nicotine content cigarettes using plasma cotinine. , 2018, Preventive medicine.

[11]  N. Benowitz Comprehensive Nicotine Regulation to End the Combustible Tobacco Epidemic , 2017, Annals of Internal Medicine.

[12]  Derek D. Reed,et al.  Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction , 2017, JAMA psychiatry.

[13]  S. Gottlieb,et al.  A Nicotine-Focused Framework for Public Health. , 2017, The New England journal of medicine.

[14]  Diane J. Martinez,et al.  Reduced nicotine content cigarettes in smokers of low socioeconomic status: study protocol for a randomized control trial , 2017, Trials.

[15]  D. Mays,et al.  Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior. , 2017, Drug and alcohol dependence.

[16]  A. Evins,et al.  A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol , 2017, BMC Public Health.

[17]  E. Donny,et al.  Low Nicotine Content Descriptors Reduce Perceived Health Risks and Positive Cigarette Ratings in Participants Using Very Low Nicotine Content Cigarettes , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[18]  K. Tang,et al.  A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[19]  Jason D. Robinson,et al.  Randomized Trial of Reduced-Nicotine Standards for Cigarettes. , 2015, The New England journal of medicine.

[20]  S. Wilson,et al.  Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[21]  D. Hatsukami,et al.  Biochemical Estimation of Noncompliance with Smoking of Very Low Nicotine Content Cigarettes , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[22]  D. Hammond,et al.  Reduced Nicotine Cigarettes: Smoking Behavior and Biomarkers of Exposure among Smokers Not Intending to Quit , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[23]  S. Hall,et al.  Smoking Behavior and Exposure to Tobacco Toxicants during 6 Months of Smoking Progressively Reduced Nicotine Content Cigarettes , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[24]  M. Munafo,et al.  Socioeconomic status and smoking: a review , 2012, Annals of the New York Academy of Sciences.

[25]  Huaqin Pan,et al.  The PhenX Toolkit: Get the Most From Your Measures , 2011, American journal of epidemiology.

[26]  G. Fong,et al.  Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western countries: findings from the International Tobacco Control Four Country Survey. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[27]  C. Backinger,et al.  Nicotine reduction revisited: science and future directions , 2010, Tobacco Control.

[28]  D. Hatsukami,et al.  Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. , 2010, Addiction.

[29]  J. Rabinowitz,et al.  Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features. , 2009, Schizophrenia bulletin.

[30]  S. Redhead FDA Tobacco Regulation: The Family Smoking Prevention and Tobacco Control Act of 2009 , 2009 .

[31]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[32]  S. Hall,et al.  Nicotine and Carcinogen Exposure with Smoking of Progressively Reduced Nicotine Content Cigarette , 2007, Cancer Epidemiology Biomarkers & Prevention.

[33]  J. Difranza,et al.  Measuring adults' loss of autonomy over nicotine use: the Hooked on Nicotine Checklist. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[34]  L. Cox,et al.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[35]  N. Benowitz,et al.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation. , 1994, The New England journal of medicine.

[36]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[37]  D. Hatsukami,et al.  Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.

[38]  A. Evins,et al.  Acceptability of SPECTRUM Research Cigarettes among Participants in Trials of Reduced Nicotine Content Cigarettes. , 2018, Tobacco regulatory science.

[39]  M. al’Absi,et al.  Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial , 2017, Addiction.

[40]  L. Valentín-Blasini,et al.  Chemical Characterization of Mainstream Smoke from SPECTRUM Variable Nicotine Research Cigarettes. , 2017, Tobacco regulatory science.

[41]  M. Mercincavage,et al.  Attrition during a randomized controlled trial of reduced nicotine content cigarettes as a proxy for understanding acceptability of nicotine product standards , 2017, Addiction.

[42]  P. Richter,et al.  Characterization of SPECTRUM Variable Nicotine Research Cigarettes. , 2016, Tobacco regulatory science.

[43]  B. Lushniak,et al.  The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .